Search results
AltruBio secures $225m for immune checkpoint programme development
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoAltruBio has secured $225m in an oversubscribed Series B financing round to progress the clinical...
What Kind Of Shareholders Hold The Majority In Viracta Therapeutics, Inc.'s (NASDAQ:VIRX) Shares?
Simply Wall St. via Yahoo Finance· 2 years agoThe big shareholder groups in Viracta Therapeutics, Inc. (NASDAQ:VIRX) have power over the company....
Private equity firms account for 49% of Akoya Biosciences, Inc.'s (NASDAQ:AKYA) ownership, while...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights Significant control over Akoya Biosciences by private equity firms implies that the...